RxNorm Concept ID 905032

risedronate sodium 30 MG Oral Tablet

Semantic Concepts

RxNorm semantic concepts for the RxCUI 905032 unique identifier include: risedronate sodium 30 MG Oral Tablet (6365636), risedronate sodium 30 MG Oral Tablet (3067140), Risedronate sodium 30 mg oral tablet (9264456) and Product containing precisely risedronate sodium 30 milligram/1 each conventional release oral tablet (clinical drug) (10316881).

RxNorm Atom ID: 6365636 - Prescribable Name

risedronate sodium 30 MG Oral Tablet

Field NameField ValueField Description
RXCUI905032RxNorm Unique Identifier for a concept (Concept ID)
LATENGLanguage of the Term
RXAUI6365636Unique identifier for the atom (RxNorm Atom ID)
Concept Descriptionrisedronate sodium 30 MG Oral TabletDescription of concept identifier
Term Type (TTY)PSNTerm type in source with name and description
Term Type NamePrescribable NameName of term type in source
Term Type DescriptionSynonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.Description of term type in source
CODE905032"Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
Is Prescribable?YESThis drug is part of the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States. The Current Prescribable subset also includes over-the-counter drugs.
Suppress FlagNSuppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility.
CVF4096Content view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
SourceRXNORMConcept source abbreviation
Source NameRxNorm VocabularyThe official name for a source
Source Version20AA_221107FThe source version
Source DateNovember 07, 2022RxNorm data last updated
Source License ContactRxNorm Customer Service

U.S. National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
(888) FIND-NLM

[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/
The source license contact information
Source Content ContactRxNorm Customer Service

U.S. National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
(888) FIND-NLM

[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/
The source content contact information
Source Short NameRxNorm work done by the National Library of MedicineThe short name of a source as used by the NLM Knowledge Source Server

RxNorm Atom ID: 3067140 - Semantic Clinical Drug

risedronate sodium 30 MG Oral Tablet

Field NameField ValueField Description
RXCUI905032RxNorm Unique Identifier for a concept (Concept ID)
LATENGLanguage of the Term
RXAUI3067140Unique identifier for the atom (RxNorm Atom ID)
Concept Descriptionrisedronate sodium 30 MG Oral TabletDescription of concept identifier
Term Type (TTY)SCDTerm type in source with name and description
Term Type NameSemantic Clinical DrugName of term type in source
Term Type DescriptionIngredient + Strength + Dose FormDescription of term type in source
CODE905032"Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
Is Prescribable?YESThis drug is part of the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States. The Current Prescribable subset also includes over-the-counter drugs.
Suppress FlagNSuppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility.
CVF4096Content view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
SourceRXNORMConcept source abbreviation
Source NameRxNorm VocabularyThe official name for a source
Source Version20AA_221107FThe source version
Source DateNovember 07, 2022RxNorm data last updated
Source License ContactRxNorm Customer Service

U.S. National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
(888) FIND-NLM

[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/
The source license contact information
Source Content ContactRxNorm Customer Service

U.S. National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
(888) FIND-NLM

[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/
The source content contact information
Source Short NameRxNorm work done by the National Library of MedicineThe short name of a source as used by the NLM Knowledge Source Server

RxNorm Atom 3067140 Attributes

PropertyValueExplanation
RXN AI{905031} 60334RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AM{905031} 55685RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AVAILABLE STRENGTH30 MG (expressed as risedronate sodium)Available drug strengths listed in the order of ingredients from the drug
RXN BOSS FROM{905031} AISource of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN HUMAN DRUGUSDrug available for use in Humans
RXTERM FORMTabThe RxTerm dose form name for this drug

RxNorm Atom ID: 9264456 - Designated preferred name

Risedronate sodium 30 mg oral tablet

Field NameField ValueField Description
RXCUI905032RxNorm Unique Identifier for a concept (Concept ID)
LATENGLanguage of the Term
RXAUI9264456Unique identifier for the atom (RxNorm Atom ID)
Concept DescriptionRisedronate sodium 30 mg oral tabletDescription of concept identifier
Term Type (TTY)PTTerm type in source with name and description
Term Type NameDesignated preferred nameName of term type in source
Term Type DescriptionDescription of term type in source
CODE325984003"Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
Is Prescribable?YESThis drug is part of the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States. The Current Prescribable subset also includes over-the-counter drugs.
Suppress FlagNSuppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility.
CVFContent view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
SourceSNOMEDCT_USConcept source abbreviation
Source NameUS Edition of SNOMED CTThe official name for a source
Source Version2022_07_31The source version
Source DateNovember 07, 2022RxNorm data last updated
Source License ContactNational Library Of Medicine
NLM is a Charter Member of SNOMED International on behalf of the U.S.
National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
1-888-FIND-NLM (1-888-346-3656)

https://support.nlm.nih.gov/support/create-case/
The source license contact information
Source Content ContactNational Library Of Medicine
NLM is a Charter Member of SNOMED International on behalf of the U.S.
National Library Of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
1-888-FIND-NLM (1-888-346-3656)

https://support.nlm.nih.gov/support/create-case/
The source content contact information
Source Short NameUS Edition of SNOMED CTThe short name of a source as used by the NLM Knowledge Source Server

RxNorm Atom ID: 10316881 - Full form of descriptor

Product containing precisely risedronate sodium 30 milligram/1 each conventional release oral tablet (clinical drug)

Field NameField ValueField Description
RXCUI905032RxNorm Unique Identifier for a concept (Concept ID)
LATENGLanguage of the Term
RXAUI10316881Unique identifier for the atom (RxNorm Atom ID)
Concept DescriptionProduct containing precisely risedronate sodium 30 milligram/1 each conventional release oral tablet (clinical drug)Description of concept identifier
Term Type (TTY)FNTerm type in source with name and description
Term Type NameFull form of descriptorName of term type in source
Term Type DescriptionDescription of term type in source
CODE325984003"Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
Is Prescribable?YESThis drug is part of the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States. The Current Prescribable subset also includes over-the-counter drugs.
Suppress FlagNSuppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility.
CVFContent view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
SourceSNOMEDCT_USConcept source abbreviation
Source NameUS Edition of SNOMED CTThe official name for a source
Source Version2022_07_31The source version
Source DateNovember 07, 2022RxNorm data last updated
Source License ContactNational Library Of Medicine
NLM is a Charter Member of SNOMED International on behalf of the U.S.
National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
1-888-FIND-NLM (1-888-346-3656)

https://support.nlm.nih.gov/support/create-case/
The source license contact information
Source Content ContactNational Library Of Medicine
NLM is a Charter Member of SNOMED International on behalf of the U.S.
National Library Of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
1-888-FIND-NLM (1-888-346-3656)

https://support.nlm.nih.gov/support/create-case/
The source content contact information
Source Short NameUS Edition of SNOMED CTThe short name of a source as used by the NLM Knowledge Source Server

* This product uses publicly available data courtesy of the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Information for Patients

Risedronate

Risedronate tablets and delayed-release (long-acting tablets) are used to prevent and treat osteoporosis (a condition in which the bones become thin and weak and break easily) in women who have undergone menopause (''change of life,'' end of menstrual periods). Risedronate tablets are also used to treat osteoporosis in men, and in men and women who are taking glucocorticoids (a type of corticosteroid medication that may cause osteoporosis). Risedronate tablets are also used to treat Paget's disease of bone (a condition in which the bones are soft and weak and may be deformed, painful, or easily broken). Risedronate is in a class of medications called bisphosphonates. It works by preventing bone breakdown and increasing bone density (thickness).
[Read More]

* Please review the disclaimer below.